FDA Discontinues Trimethobenzamide Injection (ANDA 089094)

The FDA’s drug approval database shows that the injectable product Trimethobenzamide Hydrochloride, marketed under the brand name TRIMETHOBENZAMIDE HYDROCHLORIDE with product number 001, has a marketing status of "Discontinued" under application number ANDA089094. The sponsor for this product is SoloPak. The product is an injection dosage form containing 100 mg/mL of Trimethobenzamide Hydrochloride. No reference drug or reference standard is indicated. The discontinued status means the product is no longer marketed in the United States.